| pubmed-article:8863778 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8863778 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:8863778 | lifeskim:mentions | umls-concept:C0043157 | lld:lifeskim |
| pubmed-article:8863778 | lifeskim:mentions | umls-concept:C0032105 | lld:lifeskim |
| pubmed-article:8863778 | lifeskim:mentions | umls-concept:C0003015 | lld:lifeskim |
| pubmed-article:8863778 | lifeskim:mentions | umls-concept:C0443286 | lld:lifeskim |
| pubmed-article:8863778 | lifeskim:mentions | umls-concept:C0220938 | lld:lifeskim |
| pubmed-article:8863778 | lifeskim:mentions | umls-concept:C0879489 | lld:lifeskim |
| pubmed-article:8863778 | pubmed:issue | 10 | lld:pubmed |
| pubmed-article:8863778 | pubmed:dateCreated | 1996-11-20 | lld:pubmed |
| pubmed-article:8863778 | pubmed:abstractText | Hypotensive reactions to platelet transfusions performed with white cell (WBC)-reduction filters with negatively charged surfaces have been reported recently in patients taking angiotensin-converting enzyme (ACE) inhibitors. Experimental studies have shown that the filter material can activate bradykinin, which may cause symptoms in patients with reduced bradykinin catabolism. Symptomatic adverse reactions after the administration of fresh-frozen plasma (FFP) through a WBC-reduction filter have not been reported in a patient on ACE Inhibitor medication. | lld:pubmed |
| pubmed-article:8863778 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8863778 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8863778 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8863778 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8863778 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8863778 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8863778 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:8863778 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8863778 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8863778 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8863778 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:8863778 | pubmed:issn | 0041-1132 | lld:pubmed |
| pubmed-article:8863778 | pubmed:author | pubmed-author:ChristieBB | lld:pubmed |
| pubmed-article:8863778 | pubmed:author | pubmed-author:MullinG TGT | lld:pubmed |
| pubmed-article:8863778 | pubmed:author | pubmed-author:LiuM YMY | lld:pubmed |
| pubmed-article:8863778 | pubmed:author | pubmed-author:EastlundTT | lld:pubmed |
| pubmed-article:8863778 | pubmed:author | pubmed-author:FriedM RMR | lld:pubmed |
| pubmed-article:8863778 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8863778 | pubmed:volume | 36 | lld:pubmed |
| pubmed-article:8863778 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8863778 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8863778 | pubmed:pagination | 900-3 | lld:pubmed |
| pubmed-article:8863778 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:8863778 | pubmed:meshHeading | pubmed-meshheading:8863778-... | lld:pubmed |
| pubmed-article:8863778 | pubmed:meshHeading | pubmed-meshheading:8863778-... | lld:pubmed |
| pubmed-article:8863778 | pubmed:meshHeading | pubmed-meshheading:8863778-... | lld:pubmed |
| pubmed-article:8863778 | pubmed:meshHeading | pubmed-meshheading:8863778-... | lld:pubmed |
| pubmed-article:8863778 | pubmed:meshHeading | pubmed-meshheading:8863778-... | lld:pubmed |
| pubmed-article:8863778 | pubmed:meshHeading | pubmed-meshheading:8863778-... | lld:pubmed |
| pubmed-article:8863778 | pubmed:meshHeading | pubmed-meshheading:8863778-... | lld:pubmed |
| pubmed-article:8863778 | pubmed:meshHeading | pubmed-meshheading:8863778-... | lld:pubmed |
| pubmed-article:8863778 | pubmed:meshHeading | pubmed-meshheading:8863778-... | lld:pubmed |
| pubmed-article:8863778 | pubmed:meshHeading | pubmed-meshheading:8863778-... | lld:pubmed |
| pubmed-article:8863778 | pubmed:year | 1996 | lld:pubmed |
| pubmed-article:8863778 | pubmed:articleTitle | Hypotensive reactions to white cell-reduced plasma in a patient undergoing angiotensin-converting enzyme inhibitor therapy. | lld:pubmed |
| pubmed-article:8863778 | pubmed:affiliation | American Red Cross North Central Blood Services, St. Paul Minnesota, USA. | lld:pubmed |
| pubmed-article:8863778 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8863778 | pubmed:publicationType | Case Reports | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8863778 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8863778 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8863778 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8863778 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8863778 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8863778 | lld:pubmed |
